USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
In-vitro Diagnostics Market Outlook in Australia
In-vitro Diagnostics Market Outlook in Australia
RELEASE DATE
21-Mar-2011
21-Mar-2011
REGION
Asia Pacific
Asia Pacific
Research Code: P4B8-01-00-00-00
SKU: HC02338-AP-MR_08367
$4,950.00
In stock
SKU
HC02338-AP-MR_08367
Description
This research service analyzes the IVD market in Australia strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, self-monitoring of blood glucose, and point-of-care testing, and forecasts the same until 2017. Regional attractiveness and analysis based on competitive forces are provided. In addition, the future market potential and opportunities in attractive segments are discussed in detail.
Table of Contents
Summary of the Australian IVD Market
- Title
- Disclaimer
- Certification
- Table of Contents
- List of Figures
- List of Charts
- Overview of the Australian IVD Market
Overview of this Research
- Research Objective and Methodology
- Healthcare Structure - Australia
- IVD Products - Approval Reimbursement and Procurement
- Regulation of IVD Products
- IVD Pricing Schedule from 1 July 2010
- Definitions and Abbreviations
- Scope and Segmentation
Key Industry Challenges
- Identification of Key Industry Challenges
Market Engineering Forecasts for the Australian IVD Market
- Market Overview
- Market Engineering Measurements
- Market Drivers and Restraints
- Market Lifecycle
- Revenue Forecasts - Total IVD Market
- Percent of Revenues by Segment
Market Engineering Forecasts for the Clinical Chemistry Market
- Revenue Forecasts
- Current Status
Market Engineering Forecasts for the Immunoassay Market
- Revenue Forecasts
- Current Status
Market Engineering Forecasts for the Hematology Market
- Revenue Forecasts
- Current Status
Market Engineering Forecasts for the Coagulation Market
- Revenue Forecasts
- Current Status
Market Engineering Forecasts for the Microbiology Market
- Revenue Forecasts
- Current Status
Market Engineering Forecasts for the Molecular Diagnostics Market
- Revenue Forecasts
- Current Status
Market Engineering Forecasts for the SMBG Market
- Revenue Forecasts
- Current Status
Market Engineering Forecasts for the POCT Market
- Revenue Forecasts
- Current Status
Market Competition
- Competitive Structure
- Competitive Scenario
- Market Share Analysis
Future Outlook
- IVD Business in Australia
- Customer Priorities Trajectory
- Snapshot of Potential Opportunities
- Market Attractiveness
- Opportunities in Attractive Segments
- Key Trends and Opportunities
- Impact of Top Four Trends on the Market Growth
- Conclusion and Recommendations
Database of Key Participants in the Australian IVD Market
- Database of Key Market Participants - Manufacturers and Distributors
- List of Major Laboratories and Their Location
Short Summary about Frost & Sullivan
Popular Topics
This research service analyzes the IVD market in Australia strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, self-monitoring of blood glucose, and point-of-care testing, and forecasts the same until 2017. Regional attractiveness and analysis based on competitive forces are provided. In addition, the future market potential and opportunities in attractive segments are discussed in detail.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | P4B8-01-00-00-00 |
| Is Prebook | No |